Revascularization strategies and in-hospital management in acute coronary syndromes complicated by hemophilia A or hemophilia B
Authors:
- Anne BlairABAnne Blair
- William H. MatthaiWMWilliam H. Matthai
- Rolando VegaRVRolando Vega
- Meghan BuckleyMBMeghan Buckley
- Phyllis A. GimottyPGPhyllis A. Gimotty
- Patrick F. FogartyPFPatrick F. Fogarty
- 1 December 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 28 (8) , 650-657
Abstract
Among adult patients with hemophilia A and hemophilia B the emergent management of acute coronary syndromes (ACSs) is challenging, and exposure to antithrombotic agents and/or revascularization procedures may confer an enhanced risk of bleeding. We sought to identify clinical characteristics and in-hospital outcomes among ACS patients with hemophilia A/hemophilia B, compared with matched noncoagulopathic ACS controls. Case discharges from the Nationwide Inpatient Sample, Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality (1998–2011) had International Classification of Diseases, 9th Revision codes for hemophilia A/hemophilia B and ACS. Control discharges were matched to cases by year of discharge and hospital. Discharges in both groups were assessed for cardiovascular risk factors, type of ACS, use of coronary artery bypass grafting, percutaneous coronary intervention (PCI), bare-metal stent and/or drug-eluting stent, bleeding, and death. In total, 237 cases and 148 848 matched controls were identified. Among cases, HIV/Hepatitis C positivity was more common and obesity/hyperlipidemia less common. ST-elevation myocardial infarction (STEMI) occurred less frequently among hemophilia A cases than controls. hemophilia A and hemophilia B cases were more likely to be managed medically. Cases treated with coronary stent placement were more likely to receive a bare-metal stent than controls. Among PCI, bleeding was more common among hemophilia A cases. The death rates were comparable between groups. ACS–hemophilia A/hemophilia B cases were more often treated noninvasively compared with controls, suggesting an avoidance of PCI/coronary artery bypass grafting in this population, and bleeding (among hemophilia A) was more common. These findings support further study of the management of ACS and in-hospital outcomes among individuals with hemophilia.Keywords
This publication has 32 references indexed in Scilit:
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft SurgeryJACC, 2011
- Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US)Haemophilia, 2011
- Awaiting evidence‐based recommendations on prophylaxis in adult patientsHaemophilia, 2010
- Acute coronary syndrome and severe haemophilia: An unusual association with challenging treatmentThrombosis and Haemostasis, 2010
- How I treat age-related morbidities in elderly persons with hemophiliaBlood, 2009
- Emerging clinical concerns in the ageing haemophilia patientHaemophilia, 2009
- Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIVBlood, 2007
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Mortality and causes of death in Dutch haemophiliacs, 1973–86British Journal of Haematology, 1989
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983